常规心电图筛查与成人心血管疾病事件
该研究基于日本健康保险协会数据库35至65岁全国性队列,纳入2015年4月1日至2022年3月31日数据,分析时间为2022年10月1日至2024年4月11日。基线心电图分为正常、1项次要异常、≥2项次要异常和主要异常。中位随访5.5年,相比正常心电图,1项次要异常、≥2项次要异常和主要异常的复合终点调整HR分别为1.19、1.37和1.96。次要异常的数量还与新发主要心电图异常风险升高相关,调整HR分别为2.52和3.61。作者认为常规心电图筛查对心血管事件早期预防的潜在作用及最佳随访策略有待未来研究检验。
要点
- 中位随访5.5年,复合终点(全因死亡和心肌梗死、卒中或心力衰竭住院)发生率:正常心电图92.7/万·年,1项次要异常128.5/万·年,≥2项次要异常159.7/万·年,主要异常266.3/万·年。
- 相比正常心电图,1项次要异常调整HR 1.19(95%CI 1.18-1.20),≥2项次要异常调整HR 1.37(95%CI 1.34-1.39),主要异常调整HR 1.96(95%CI 1.92-2.02)。
- 基线次要心电图异常的存在和数量与新发主要心电图异常风险升高相关,1项次要异常调整HR 2.52(95%CI 2.49-2.55),≥2项次要异常调整HR 3.61(95%CI 3.55-3.67)。
- 无论基线心血管疾病风险如何,心电图异常与复合终点的关联均存在。
- 作者认为,常规心电图筛查在心血管事件早期预防中的潜在作用及最佳随访策略应在未来研究中检验。
适用人群与场景
- 日本健康保险协会数据库覆盖的35至65岁在职人群,2015年4月1日至2022年3月31日期间参加年度健康检查者,共3 698 429人(平均[SD]年龄47.1[8.5]岁,66.6%为男性)。
诊断标准与关键阈值
- 基线心电图状态分为正常、1项次要异常、≥2项次要异常或主要异常。
研究设计与关键结果
- 研究类型为全国性队列研究,纳入3 698 429名35至65岁在职人群,基线心电图异常分布:1项次要异常623 073人(16.8%),≥2项次要异常144 535人(3.9%),主要异常56 921人(1.5%)。
- 中位随访5.5年(IQR 3.4-5.7),复合终点(全因死亡和因心肌梗死、卒中或心力衰竭住院)发生率:正常心电图92.7/万·年(95%CI 92.2-93.2),1项次要异常128.5/万·年(95%CI 127.2-129.9),≥2项次要异常159.7/万·年(95%CI 156.6-162.9),主要异常266.3/万·年(95%CI 259.9-272.3)。
- 相比正常心电图,复合终点调整HR:1项次要异常1.19(95%CI 1.18-1.20),≥2项次要异常1.37(95%CI 1.34-1.39),主要异常1.96(95%CI 1.92-2.02)。
- 新发主要心电图异常发生率:正常心电图85.1/万·年(95%CI 84.5-85.5),1项次要异常217.2/万·年(95%CI 215.5-219.0),≥2项次要异常306.4/万·年(95%CI 302.1-310.7);调整HR:1项次要异常2.52(95%CI 2.49-2.55),≥2项次要异常3.61(95%CI 3.55-3.67)。
- 无论基线心血管疾病风险如何,心电图异常与复合终点的关联均存在。
证据类型、等级与局限
- 证据类型:全国性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究提示,在35至65岁在职人群中,基线心电图次要或主要异常与全因死亡和心血管病住院复合终点风险升高独立相关,无论基线心血管疾病风险如何。
- 作者认为,常规心电图筛查在心血管事件早期预防中的潜在作用及最佳随访策略应在未来研究中检验。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The resting electrocardiogram (ECG) is commonly performed for cardiovascular disease (CVD) screening purposes in Japan. However, evidence is limited regarding the prognostic significance of ECG in clinical practice settings.
OBJECTIVE: To investigate the association between ECG abnormalities and CVD outcomes in a working-age population.
DESIGN, SETTING, AND PARTICIPANTS: This nationwide cohort study included individuals aged 35 to 65 years from the Japan Health Insurance Association database, which covers approximately 40% (30 million) of the working-age population in Japan. Data from April 1, 2015, to March 31, 2022, were included, and analysis was conducted from October 1, 2022, to April 11, 2024.
EXPOSURES: Baseline ECG status (normal, 1 minor abnormality, ≥2 minor abnormalities, or major abnormality).
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of overall death and CVD hospital admission due to myocardial infarction, stroke, or heart failure. The secondary outcome was developing a new major ECG abnormality over the years of screening.
RESULTS: Of 3 698 429 individuals enrolled in the nationwide annual health check program (mean [SD] age, 47.1 [8.5] years; 66.6% male), 623 073 (16.8%) had 1 minor ECG abnormality, 144 535 (3.9%) had 2 or more minor ECG abnormalities, and 56 921 (1.5%) had a major ECG abnormality. During a median follow-up of 5.5 (IQR, 3.4-5.7) years, baseline ECG abnormality was independently associated with an increased incidence of the composite end points of overall death and CVD admission compared with normal ECG (incidence rates per 10 000 person-years: 92.7 [95% CI, 92.2-93.2] for normal ECG, 128.5 [95% CI, 127.2-129.9] for 1 minor ECG abnormality, 159.7 [95% CI, 156.6-162.9] for ≥2 minor ECG abnormalities, and 266.3 [95% CI, 259.9-272.3] for a major ECG abnormality; adjusted hazard ratios: 1.19 [95% CI, 1.18-1.20] for 1 minor ECG abnormality, 1.37 [95% CI, 1.34-1.39] for ≥2 minor ECG abnormalities, and 1.96 [95% CI, 1.92-2.02] for a major ECG abnormality). Furthermore, the presence and number of minor ECG abnormalities were associated with an increased incidence of developing new major ECG abnormalities (incidence rates per 10 000 person-years: 85.1 [95% CI, 84.5-85.5] for normal ECG, 217.2 [95% CI, 215.5-219.0] for 1 minor ECG abnormality, and 306.4 [95% CI, 302.1-310.7] for ≥2 minor ECG abnormalities; and adjusted hazard ratios: 2.52 [95% CI, 2.49-2.55] for 1 minor ECG abnormality and 3.61 [95% CI, 3.55-3.67] for ≥2 minor ECG abnormalities). Associations were noted regardless of baseline CVD risk.
CONCLUSIONS AND RELEVANCE: The findings of this study suggest that the potential role of routine ECG screening for early prevention of CVD events, along with the optimal follow-up strategy, should be examined in future studies.
参考来源
- Yagi R, Mori Y, Goto S, et al. Routine Electrocardiogram Screening and Cardiovascular Disease Events in Adults. JAMA Intern Med. 2024. PMID: 38949831. doi:10.1001/jamainternmed.2024.2270
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。